Efficacy and safety of onabotulinumtoxinA in pediatric patients with chronic migraine

被引：0
|
作者：
Caronna, E. [1 ]
Mas-de-les-Valls-Cerco, R. [1 ]
Gallardo, V. J. [1 ]
Gomez-Dabo, L. [1 ]
Alpuente, A. [1 ]
Torres-Ferrus, M. [1 ]
Pozo-Rosich, P. [1 ]
机构：
[1] Univ Autonoma Barcelona, Vall dHebron Hosp & Res Inst, Dept Neurol, Headache Clin, Barcelona, Spain
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P158
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy and Tolerability of CGRP Monoclonal Antibody Medications in Patients With Chronic Migraine Undergoing Treatment With OnabotulinumtoxinA
    Cohen, F.
    Armand, C. E.
    Vollbracht, S. E.
    HEADACHE, 2020, 60 : 13 - 13
  • [42] OnabotulinumtoxinA for Treatment of Chronic Migraine
    Markert, Ronald J.
    Solomon, Glen D.
    HEADACHE, 2011, 51 (06): : 1002 - 1003
  • [43] Comparison of the efficacy of onabotulinumtoxinA in new daily persistent headache to chronic migraine
    Cheema, Sanjay
    Lagrata, Susie
    Ahmed, Maha
    Kamourieh, Salwa
    Matharu, Manjit
    CEPHALALGIA, 2023, 43 (1supp) : 281 - 281
  • [44] Long-term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis
    Argyriou, Andreas A.
    Dermitzakis, Emmanouil, V
    Vlachos, George S.
    Vikelis, Michail
    ACTA NEUROLOGICA SCANDINAVICA, 2022, 145 (06): : 676 - 683
  • [45] Long-term safety and efficacy of onabotulinumtoxinA for the prevention of chronic migraine in a South Korean population: COMPEL study
    Kim, Byung-Kun
    Chu, Min Kyung
    Adams, Aubrey Manack
    Blumenfeld, Andrew M.
    NEUROLOGY ASIA, 2019, 24 (02) : 127 - 137
  • [46] Treatment of Chronic Migraine Using OnabotulinumtoxinA May be Less Effective in Pediatric Patients with History of Depression or Anxiety
    O'Brien, H.
    Kabbouche, M.
    Kacperski, J.
    Hershey, A. D.
    Horn, P.
    Vaughan, P.
    Slater, S.
    Wood, B.
    HEADACHE, 2014, 54 : 45 - 45
  • [47] Efficacy of onabotulinumtoxinA treatment in episodic migraine
    Al-Hashel, Jasem
    Alroughani, Raed
    Almojel, Malak
    Ahmed, Samar Farouk
    FRONTIERS IN NEUROLOGY, 2025, 15
  • [48] Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study
    Paul K. Winner
    Andrew M. Blumenfeld
    Eric J. Eross
    Amelia C. Orejudos
    Debbie L. Mirjah
    Aubrey Manack Adams
    Mitchell F. Brin
    Drug Safety, 2019, 42 : 1013 - 1024
  • [49] Safety and Efficacy of Melatonin in Pediatric Migraine Prophylaxis
    Fallah, Razieh
    Shoroki, Fatemeh F.
    Ferdosian, Farzad
    CURRENT DRUG SAFETY, 2015, 10 (02) : 132 - 135
  • [50] OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience
    Chiang, Chia-Chun
    Starling, Amaal J.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 10 (12) : 397 - 406
12345